Officials selected Shu-Hsia Chen, PhD, to lead the center. Her research focuses on developing therapies to change the tumor microenvironment in cancer patients and those affected by chronic inflammatory diseases. Dr. Chen’s research has received support from the National Institutes of Health, the U.S. Department of Defense and several companies.
Her 10-member team also includes senior researcher Ping-Ying Pan, PhD, who will serve as co-director of the center. Officials said Dr. Pan will work closely with Houston Methodist’s Immunobiology and Transplant Science Center.
More articles on hospital-physician relationships:
Joint Commission conducts nonroutine accreditation survey of University of Minnesota hospital
Pennsylvania physicians help birth endangered gorilla at Philadelphia Zoo
Nevada legislators set aside $25M in funding for University of Nevada medical school
